Cargando…

Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors

BACKGROUND: The level of access to intermittent preventive treatment for malaria in pregnancy (IPTp) in Nigeria is still low despite relatively high antenatal care coverage in the study area. This paper presents information on provider factors that affect the delivery of IPTp in Nigeria. METHODS: Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoka, Chima A, Onwujekwe, Obinna E, Hanson, Kara, Uzochukwu, Benjamin S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468404/
https://www.ncbi.nlm.nih.gov/pubmed/22958539
http://dx.doi.org/10.1186/1475-2875-11-317
_version_ 1782245945771032576
author Onoka, Chima A
Onwujekwe, Obinna E
Hanson, Kara
Uzochukwu, Benjamin S
author_facet Onoka, Chima A
Onwujekwe, Obinna E
Hanson, Kara
Uzochukwu, Benjamin S
author_sort Onoka, Chima A
collection PubMed
description BACKGROUND: The level of access to intermittent preventive treatment for malaria in pregnancy (IPTp) in Nigeria is still low despite relatively high antenatal care coverage in the study area. This paper presents information on provider factors that affect the delivery of IPTp in Nigeria. METHODS: Data were collected from heads of maternal health units of 28 public and six private health facilities offering antenatal care (ANC) services in two districts in Enugu State, south-east Nigeria. Provider knowledge of guidelines for IPTp was assessed with regard to four components: the drug used for IPTp, time of first dose administration, of second dose administration, and the strategy for sulphadoxine-pyrimethamine (SP) administration (directly observed treatment, DOT). Provider practices regarding IPTp and facility-related factors that may explain observations such as availability of SP and water were also examined. RESULTS: Only five (14.7%) of all 34 providers had correct knowledge of all four recommendations for provision of IPTp. None of them was a private provider. DOT strategy was practiced in only one and six private and public providers respectively. Overall, 22 providers supplied women with SP in the facility and women were allowed to take it at home. The most common reason for doing so amongst public providers was that women were required to come for antenatal care on empty stomachs to enhance the validity of manual fundal height estimation. Two private providers did not think it was necessary to use the DOT strategy because they assumed that women would take their drugs at home. Availability of SP and water in the facility, and concerns about side effects were not considered impediments to delivery of IPTp. CONCLUSION: There was low level of knowledge of the guidelines for implementation of IPTp by all providers, especially those in the private sector. This had negative effects such as non-practice of DOT strategy by most of the providers, which can lead to low levels of adherence to IPTp and ineffectiveness of IPTp. Capacity development and regular supportive supervisory visits by programme managers could help improve the provision of IPTp.
format Online
Article
Text
id pubmed-3468404
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34684042012-10-11 Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors Onoka, Chima A Onwujekwe, Obinna E Hanson, Kara Uzochukwu, Benjamin S Malar J Research BACKGROUND: The level of access to intermittent preventive treatment for malaria in pregnancy (IPTp) in Nigeria is still low despite relatively high antenatal care coverage in the study area. This paper presents information on provider factors that affect the delivery of IPTp in Nigeria. METHODS: Data were collected from heads of maternal health units of 28 public and six private health facilities offering antenatal care (ANC) services in two districts in Enugu State, south-east Nigeria. Provider knowledge of guidelines for IPTp was assessed with regard to four components: the drug used for IPTp, time of first dose administration, of second dose administration, and the strategy for sulphadoxine-pyrimethamine (SP) administration (directly observed treatment, DOT). Provider practices regarding IPTp and facility-related factors that may explain observations such as availability of SP and water were also examined. RESULTS: Only five (14.7%) of all 34 providers had correct knowledge of all four recommendations for provision of IPTp. None of them was a private provider. DOT strategy was practiced in only one and six private and public providers respectively. Overall, 22 providers supplied women with SP in the facility and women were allowed to take it at home. The most common reason for doing so amongst public providers was that women were required to come for antenatal care on empty stomachs to enhance the validity of manual fundal height estimation. Two private providers did not think it was necessary to use the DOT strategy because they assumed that women would take their drugs at home. Availability of SP and water in the facility, and concerns about side effects were not considered impediments to delivery of IPTp. CONCLUSION: There was low level of knowledge of the guidelines for implementation of IPTp by all providers, especially those in the private sector. This had negative effects such as non-practice of DOT strategy by most of the providers, which can lead to low levels of adherence to IPTp and ineffectiveness of IPTp. Capacity development and regular supportive supervisory visits by programme managers could help improve the provision of IPTp. BioMed Central 2012-09-07 /pmc/articles/PMC3468404/ /pubmed/22958539 http://dx.doi.org/10.1186/1475-2875-11-317 Text en Copyright ©2012 Onoka et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Onoka, Chima A
Onwujekwe, Obinna E
Hanson, Kara
Uzochukwu, Benjamin S
Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title_full Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title_fullStr Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title_full_unstemmed Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title_short Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
title_sort sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in nigeria: influence of provider factors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468404/
https://www.ncbi.nlm.nih.gov/pubmed/22958539
http://dx.doi.org/10.1186/1475-2875-11-317
work_keys_str_mv AT onokachimaa suboptimaldeliveryofintermittentpreventivetreatmentformalariainpregnancyinnigeriainfluenceofproviderfactors
AT onwujekweobinnae suboptimaldeliveryofintermittentpreventivetreatmentformalariainpregnancyinnigeriainfluenceofproviderfactors
AT hansonkara suboptimaldeliveryofintermittentpreventivetreatmentformalariainpregnancyinnigeriainfluenceofproviderfactors
AT uzochukwubenjamins suboptimaldeliveryofintermittentpreventivetreatmentformalariainpregnancyinnigeriainfluenceofproviderfactors